Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors
- PMID: 86163
Item in Clipboard
Serum alpha-fetoprotein and human chorionic gonadotropin in the management of testicular tumors
Natl Cancer Inst Monogr.
1978 Dec.
Abstract
The new radioimmunoassays for AFP and beta-HCG are highly specific for nonseminomatous, germ-cell testicular tumor in genitourinary patients who do not have liver disease or other cancers. When used together, they are an accurate and sensitive indicator of metastases and are helpful in determining the effectiveness of therapy. However, they are not very useful in the differential diagnosis of scrotal masses.
Similar articles
-
Serum alpha fetoprotein and human chorionic gonadotropin in the diagnosis and management of nonseminomatous germ-cell testicular cancer.N Engl J Med. 1976 Nov 25;295(22):1237-40. doi: 10.1056/NEJM197611252952207. N Engl J Med. 1976. PMID: 62281 No abstract available.
-
Applications of biologic tumor markers in testicular cancer.Cancer Treat Rep. 1979 Sep-Oct;63(9-10):1643-7. Cancer Treat Rep. 1979. PMID: 91433
-
[Diagnostic progress in testicular carcinoma].Acta Med Austriaca. 1978;5(4-5):159-61. Acta Med Austriaca. 1978. PMID: 91300 German.
-
The clinical significance of human alpha-fetoprotein.Ann Clin Lab Sci. 1978 Mar-Apr;8(2):84-90. Ann Clin Lab Sci. 1978. PMID: 76458 Review.
-
Current status of tumor markers in testicular cancer. A practical review.Eur Urol. 1992;21 Suppl 1:34-6. doi: 10.1159/000474885. Eur Urol. 1992. PMID: 1385131 Review.